Cardiovascular disease risk profiles in inflammatory joint disease entities

Grunde Wibetoe1,2, Eirik Ikdahl3, Silvia Rollefstad3

  • 1Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23, Vinderen, N-0319, Oslo, Norway. g-wibeto@diakonsyk.no.

Insights

Patients with inflammatory joint diseases (IJD) face a higher cardiovascular disease (CVD) risk. While absolute risk appears low, relative CVD risk is significantly elevated, necessitating proactive risk assessment for all IJD patients.

Area of Science:

  • Rheumatology
  • Cardiology
  • Public Health

Background:

  • Patients with inflammatory joint diseases (IJD) exhibit an elevated risk of cardiovascular disease (CVD).
  • This study focuses on rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), and psoriatic arthritis (PsA) within the IJD spectrum.

Purpose of the Study:

  • To compare cardiovascular disease (CVD) risk profiles across RA, axSpA, and PsA patients.
  • To evaluate the future risk of CVD in individuals diagnosed with these inflammatory joint diseases.

Main Methods:

  • Prevalence and number of major CVD risk factors (hypertension, hypercholesterolemia, obesity, smoking, diabetes) were assessed.
  • Relative and absolute CVD risk were calculated using the Systematic Coronary Risk Evaluation (SCORE) model.
  • Data from 3791 patients were analyzed.

Main Results:

  • Hypertension (49.8%) and elevated cholesterol (32.8%) were the most common CVD risk factors among patients without established CVD.
  • Over 73% of patients had at least one CVD risk factor, increasing with age.
  • While absolute CVD risk was generally low, relative risk was markedly high, with 24.7% having at least three times the risk of individuals without CVD risk factors.

Conclusions:

  • Cardiovascular disease risk factors are comparably prevalent across RA, axSpA, and PsA.
  • Despite low absolute CVD risk scores, patients with IJD face a significantly higher relative risk of CVD.
  • Routine CVD risk assessment is crucial for all patients diagnosed with inflammatory joint diseases.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
776
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
641
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
420
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
17.4K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
615